Literature DB >> 17897827

A multigram chemical synthesis of the gamma-secretase inhibitor LY411575 and its diastereoisomers.

Abdul H Fauq1, Katherine Simpson, Ghulam M Maharvi, Todd Golde, Pritam Das.   

Abstract

An improved chemical synthesis of N-2((2S)-2-(3,5-difluorophenyl)-2-hydroxyethanoyl)-N1-((7S)-5-methyl-6-oxo-6,7-dihydro-5H-dibenzo[b,d]azepin-7-yl)-l-alaninamide (LY411,575, 9a), a known gamma-secretase inhibitor, is described. The key synthetic steps, which used no chiral chromatography in the entire sequence, involved (1) improved microwave-assisted synthesis of a seven-membered lactam (+/-)-(5,7-dihydro-6H-dibenz-[b,d]azepin-6-one 2, and (2) convenient isolation of pure LY411575 from a mixture of four diastereomers by simple flash silica gel chromatography. Starting from the resolved aminolactams 5a and 5b, all four diastereomers were produced in enantiomerically pure form.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17897827      PMCID: PMC2962444          DOI: 10.1016/j.bmcl.2007.07.062

Source DB:  PubMed          Journal:  Bioorg Med Chem Lett        ISSN: 0960-894X            Impact factor:   2.823


  13 in total

Review 1.  Alzheimer's disease: genes, proteins, and therapy.

Authors:  D J Selkoe
Journal:  Physiol Rev       Date:  2001-04       Impact factor: 37.312

Review 2.  Aph-1, Pen-2, and Nicastrin with Presenilin generate an active gamma-Secretase complex.

Authors:  Bart De Strooper
Journal:  Neuron       Date:  2003-04-10       Impact factor: 17.173

Review 3.  The role of A beta 42 in Alzheimer's disease.

Authors:  S G Younkin
Journal:  J Physiol Paris       Date:  1998 Jun-Aug

4.  Application of the palladium-catalyzed borylation/Suzuki coupling (BSC) reaction to the synthesis of biologically active biaryl lactams.

Authors:  Olivier Baudoin; Michèle Cesario; Daniel Guénard; Françoise Guéritte
Journal:  J Org Chem       Date:  2002-02-22       Impact factor: 4.354

5.  Two transmembrane aspartates in presenilin-1 required for presenilin endoproteolysis and gamma-secretase activity.

Authors:  M S Wolfe; W Xia; B L Ostaszewski; T S Diehl; W T Kimberly; D J Selkoe
Journal:  Nature       Date:  1999-04-08       Impact factor: 49.962

6.  A presenilin-1-dependent gamma-secretase-like protease mediates release of Notch intracellular domain.

Authors:  B De Strooper; W Annaert; P Cupers; P Saftig; K Craessaerts; J S Mumm; E H Schroeter; V Schrijvers; M S Wolfe; W J Ray; A Goate; R Kopan
Journal:  Nature       Date:  1999-04-08       Impact factor: 49.962

7.  The role of presenilin cofactors in the gamma-secretase complex.

Authors:  Nobumasa Takasugi; Taisuke Tomita; Ikuo Hayashi; Makiko Tsuruoka; Manabu Niimura; Yasuko Takahashi; Gopal Thinakaran; Takeshi Iwatsubo
Journal:  Nature       Date:  2003-03-16       Impact factor: 49.962

Review 8.  Disease modifying therapy for AD?

Authors:  Todd E Golde
Journal:  J Neurochem       Date:  2006-11       Impact factor: 5.372

Review 9.  Gamma-secretase: a catalyst of Alzheimer disease and signal transduction.

Authors:  Y M Li
Journal:  Mol Interv       Date:  2001-10

10.  Alzheimer disease in the US population: prevalence estimates using the 2000 census.

Authors:  Liesi E Hebert; Paul A Scherr; Julia L Bienias; David A Bennett; Denis A Evans
Journal:  Arch Neurol       Date:  2003-08
View more
  21 in total

1.  Gamma-secretase inhibitors enhance temozolomide treatment of human gliomas by inhibiting neurosphere repopulation and xenograft recurrence.

Authors:  Candace A Gilbert; Marie-Claire Daou; Richard P Moser; Alonzo H Ross
Journal:  Cancer Res       Date:  2010-08-24       Impact factor: 12.701

2.  γ-Secretase processing and effects of γ-secretase inhibitors and modulators on long Aβ peptides in cells.

Authors:  Yong Ran; Pedro E Cruz; Thomas B Ladd; Abdul H Fauq; Joo In Jung; Julian Matthews; Kevin M Felsenstein; Todd E Golde
Journal:  J Biol Chem       Date:  2013-12-18       Impact factor: 5.157

3.  Reducing available soluble β-amyloid prevents progression of cerebral amyloid angiopathy in transgenic mice.

Authors:  Julia L Gregory; Claudia M Prada; Sara J Fine; Monica Garcia-Alloza; Rebecca A Betensky; Michal Arbel-Ornath; Steven M Greenberg; Brian J Bacskai; Matthew P Frosch
Journal:  J Neuropathol Exp Neurol       Date:  2012-11       Impact factor: 3.685

4.  Hdac1 Regulates Differentiation of Bipotent Liver Progenitor Cells During Regeneration via Sox9b and Cdk8.

Authors:  Sungjin Ko; Jacquelyn O Russell; Jianmin Tian; Ce Gao; Makoto Kobayashi; Rilu Feng; Xiaodong Yuan; Chen Shao; Huiguo Ding; Minakshi Poddar; Sucha Singh; Joseph Locker; Hong-Lei Weng; Satdarshan P Monga; Donghun Shin
Journal:  Gastroenterology       Date:  2018-09-26       Impact factor: 22.682

5.  Metabolic regulation of cellular plasticity in the pancreas.

Authors:  Nikolay Ninov; Daniel Hesselson; Philipp Gut; Amy Zhou; Kevin Fidelin; Didier Y R Stainier
Journal:  Curr Biol       Date:  2013-06-20       Impact factor: 10.834

6.  Differential accumulation of secreted AbetaPP metabolites in ocular fluids.

Authors:  Annamalai Prakasam; Anusuya Muthuswamy; Zsolt Ablonczy; Nigel H Greig; Abdul Fauq; Kosagisharaf Jagannatha Rao; Miguel A Pappolla; Kumar Sambamurti
Journal:  J Alzheimers Dis       Date:  2010       Impact factor: 4.472

7.  Enantioselective synthesis of α-oxy amides via Umpolung amide synthesis.

Authors:  Matthew W Leighty; Bo Shen; Jeffrey N Johnston
Journal:  J Am Chem Soc       Date:  2012-09-11       Impact factor: 15.419

8.  Notch3 signaling gates cell cycle entry and limits neural stem cell amplification in the adult pallium.

Authors:  Alessandro Alunni; Monika Krecsmarik; Adriana Bosco; Sonya Galant; Luyuan Pan; Cecilia B Moens; Laure Bally-Cuif
Journal:  Development       Date:  2013-07-17       Impact factor: 6.868

9.  A gamma-secretase inhibitor and quinacrine reduce prions and prevent dendritic degeneration in murine brains.

Authors:  Patricia Spilman; Pierre Lessard; Mamta Sattavat; Clarissa Bush; Thomas Tousseyn; Eric J Huang; Kurt Giles; Todd Golde; Pritam Das; Abdul Fauq; Stanley B Prusiner; Stephen J Dearmond
Journal:  Proc Natl Acad Sci U S A       Date:  2008-07-22       Impact factor: 11.205

10.  Existing plaques and neuritic abnormalities in APP:PS1 mice are not affected by administration of the gamma-secretase inhibitor LY-411575.

Authors:  Monica Garcia-Alloza; Meenakshi Subramanian; Diana Thyssen; Laura A Borrelli; Abdul Fauq; Pritam Das; Todd E Golde; Bradley T Hyman; Brian J Bacskai
Journal:  Mol Neurodegener       Date:  2009-05-06       Impact factor: 14.195

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.